HUP0500100A2 - 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents

1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk Download PDF

Info

Publication number
HUP0500100A2
HUP0500100A2 HU0500100A HUP0500100A HUP0500100A2 HU P0500100 A2 HUP0500100 A2 HU P0500100A2 HU 0500100 A HU0500100 A HU 0500100A HU P0500100 A HUP0500100 A HU P0500100A HU P0500100 A2 HUP0500100 A2 HU P0500100A2
Authority
HU
Hungary
Prior art keywords
propenone
amino
methoxy
trimethoxyphenyl
methyl
Prior art date
Application number
HU0500100A
Other languages
English (en)
Hungarian (hu)
Inventor
Patrick Mailliet
Cécile Combeau
Marie-Christine Bissery
Marie-Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0500100A2 publication Critical patent/HUP0500100A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Detergent Compositions (AREA)
HU0500100A 2001-12-05 2002-12-03 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk HUP0500100A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14
PCT/FR2002/004143 WO2003048106A2 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
HUP0500100A2 true HUP0500100A2 (hu) 2005-05-30

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500100A HUP0500100A2 (hu) 2001-12-05 2002-12-03 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk

Country Status (23)

Country Link
EP (1) EP1453790A2 (sr)
JP (1) JP2005531494A (sr)
KR (1) KR20050044712A (sr)
CN (1) CN1612856A (sr)
AR (1) AR037479A1 (sr)
AU (1) AU2002365644A1 (sr)
BR (1) BR0214694A (sr)
CA (1) CA2469193A1 (sr)
CO (1) CO5580759A2 (sr)
EA (1) EA006803B1 (sr)
HR (1) HRP20040508A2 (sr)
HU (1) HUP0500100A2 (sr)
IL (1) IL162223A0 (sr)
MA (1) MA27351A1 (sr)
MX (1) MXPA04005226A (sr)
NZ (1) NZ533224A (sr)
PA (1) PA8558501A1 (sr)
PE (1) PE20030758A1 (sr)
PL (1) PL370676A1 (sr)
RS (1) RS47804A (sr)
SV (1) SV2003001422A (sr)
TW (1) TW200300685A (sr)
WO (1) WO2003048106A2 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (en) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
KR102636496B1 (ko) 2018-09-14 2024-02-15 삼성전자주식회사 통신 장치 및 이를 포함하는 전자 장치
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
AU708925B2 (en) * 1995-12-01 1999-08-19 Kyowa Hakko Kogyo Co. Ltd. Propenone derivatives
EP0996432A2 (en) * 1997-06-26 2000-05-03 Statens Seruminstitut Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

Also Published As

Publication number Publication date
AU2002365644A1 (en) 2003-06-17
EP1453790A2 (fr) 2004-09-08
TW200300685A (en) 2003-06-16
CO5580759A2 (es) 2005-11-30
JP2005531494A (ja) 2005-10-20
WO2003048106A2 (fr) 2003-06-12
MA27351A1 (fr) 2005-06-01
CN1612856A (zh) 2005-05-04
PE20030758A1 (es) 2003-10-07
MXPA04005226A (es) 2004-10-11
WO2003048106A3 (fr) 2004-03-25
EA200400764A1 (ru) 2004-12-30
SV2003001422A (es) 2003-07-10
EA006803B1 (ru) 2006-04-28
BR0214694A (pt) 2004-12-14
HRP20040508A2 (en) 2005-08-31
AR037479A1 (es) 2004-11-10
PL370676A1 (en) 2005-05-30
NZ533224A (en) 2006-03-31
CA2469193A1 (fr) 2003-06-12
IL162223A0 (en) 2005-11-20
PA8558501A1 (es) 2003-09-05
RS47804A (sr) 2006-12-15
KR20050044712A (ko) 2005-05-12

Similar Documents

Publication Publication Date Title
KR102642823B1 (ko) 모발 성장을 조절하기 위한 조성물 및 방법
US10889590B2 (en) Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents
JP4989976B2 (ja) 翻訳開始阻害剤としての３−３−二置換オキシインドール
KR20130115300A (ko) 단백질 탈아세틸화 효소 억제제로서 피리미딘 하이드록시 아미드 화합물 및 그의 사용방법
EP3906240A1 (en) Compositions and methods for modulating hair growth
EP3168217A1 (fr) Nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH08505375A (ja) 置換基をもつトリオール類
HU229254B1 (en) Novel indole derivatives and their use as medicaments
EP3400210B1 (fr) Composés"multi-cibles"à activité inhibitrice des histone-désacétylases et de la polymérisation de la tubuline pour son utilisation dans le traitement du cancer
HUP0500100A2 (hu) 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US5905149A (en) Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors
HU219232B (en) Bis-naphthalimide derivatives, process for producing them, and pharmaceutical compositions containing them
AU2007242793A1 (en) Synthesis and uses of pyroglutamic acid derivatives
US20030153611A1 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof
EA013542B1 (ru) Производные индола, обладающие противоопухолевой активностью
WO2024175659A1 (en) 3ah-cyclopenta[b]benzofuran-3a-yl as ras inhibitors
ES2240564T3 (es) Agentes antinflamatorios.
JP2005503376A (ja) インダゾールまたはインドール誘導体およびヒトの医療、より詳しくは癌の治療におけるそれらの使用
CN102241665B (zh) 4-(4,5-二甲氧羰基-1,3-二硫戊环-2-基)苯甲酰-l-氨基酸苄酯及其合成方法和应用
US6887904B2 (en) Substituted arylcycloalkanes, compositions containing them and use thereof
JP2006525291A (ja) １−アリール−３−（インドール−５−イル）プロパ−２−エン−１−オン、該化合物を含む組成物、及びそれらの使用
FR2967675A1 (fr) Derives fluorescents de cyanines polyamines en tant que sonde de diagnostic
FR2787793A1 (fr) Composes pseudopeptidiques dotes d'une activite inhibitrice a l'egard des voies activees par les proteines a activite tyrosine kinase et les compositions pharmaceutiques les contenant
JPS61100595A (ja) 新規なジペプチド誘導体
HK1093984B (en) Novel crystalline forms of perindopril erbumine

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees